High Court Refuses Ranbaxy's Lipitor Appeal
By Marius Meland · April 2, 2007, 12:00 AM EDT
The U.S. Supreme Court refused Monday to intervene in Ranbaxy Laboratories Ltd.'s appeal of an appeals court ruling that upheld a Pfizer Inc. patent for the cholesterol-lowering drug Lipitor, the world's...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login